Sanofi’s 340B Rebate Model: A Joint Effor...

By Rene Pretorius

November 29, 2024

How can a rebate model reshape the 340B Drug Pricing Program to address inefficiencies and abuses? Sanofi has introduced a 340B rebate model as a potential solution to long-standing challenges within the program. The
Global HIV/AIDS and Sub-Saharan Africa breakthroughs
Addressing Physical Inactivity in MENA and Beyond
Enhancing Primary Health Care Services: Strategies and Insights
Transforming Healthcare: Key Trends in South African Healthtech
Battling Antimicrobial Resistance in Northwest Syria: A Call for Urgent Action
Boosting Biopharma SMEs in Europe
Lawsuits Challenge 340B Drug Pricing Program: Eli Lilly and J&J vs. HRSA
WHO Investment Round: Securing Funding with Transparency Challenges
HPV vaccination South Africa: Cervical Cancer Prevention
Mpox Outbreak in Africa: Singapore and Africa CDC Collaborate
Rising Diabetes Prevalence in the Middle East and North Africa
Strengthening AMR Surveillance in Africa